Trial intelligence / Profile preview

Low-dose continuous norepinephrine infusion to prevent post-spinal hypotension in preeclampsia cesarean section

ChiCTR2300078736Phase 4Recruiting

Sponsor
Women's Hospital, Zhejiang University School of Medicine
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of norepinephrine in preeclampsia and hypotension, sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoint: Incidence of hypotension after spinal anesthesia. Started Dec 2023; status: recruiting.

02

Drugs

norepinephrine
03

Conditions

preeclampsiahypotension

Beyond the preview

Go deeper on ChiCTR2300078736.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300078736.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call